CN102070697A — 一种齐墩果酸衍生物、其制备方法及用途
Assigned to China Pharmaceutical University · Expires 2011-05-25 · 15y expired
What this patent protects
本发明涉及药物领域,具体涉及一种式(I)所示的齐墩果酸衍生物或其药学上可接受的盐、其制备方法和用途。本发明还公开了式(I)所示的化合物在制备抗肿瘤药物2-氰基-3,12-二氧代齐墩果烷-1,9(11)-二烯-28-羧酸(XI,CDDO)、2-氰基-3,12-二氧代齐墩果烷-1,9(11)-二烯-28-羧酰咪唑(XIII,CDDO-Im)和2-氰基-3,12-二氧代齐墩果烷-1,9(11)-二烯-28-羧酰甲胺(XIV,CDDO-MA)中的应用。
USPTO Abstract
本发明涉及药物领域,具体涉及一种式(I)所示的齐墩果酸衍生物或其药学上可接受的盐、其制备方法和用途。本发明还公开了式(I)所示的化合物在制备抗肿瘤药物2-氰基-3,12-二氧代齐墩果烷-1,9(11)-二烯-28-羧酸(XI,CDDO)、2-氰基-3,12-二氧代齐墩果烷-1,9(11)-二烯-28-羧酰咪唑(XIII,CDDO-Im)和2-氰基-3,12-二氧代齐墩果烷-1,9(11)-二烯-28-羧酰甲胺(XIV,CDDO-MA)中的应用。
Drugs covered by this patent
- Skyclarys (OMAVELOXOLONE) · Biogen Us
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.